Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Social Capital Suvretta Holdings Corp. I was a blank check company (SPAC) that completed a reverse merger with Akili Interactive Labs, Inc. on August 19, 2022. The SPAC was formed to identify and merge with a biotech target in the neurology subsector, focusing on therapeutics, novel platforms and other modalities to help manage and treat brain and nervous system disorders, including neurologic and psychiatric diseases and pain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Social Capital Suvretta Holdings Corp. I.